(Opens in a new window)Eight Ohio biomedical companies have received a total of $8 million in grants from the state’s Third Frontier technology support program.
The grants, which awarded about $1 million to each firm, are aimed at accelerating the growth and development of Ohio’s burgeoning biomedical industry, which saw its number of jobs (Opens in a new window) grow by 20 percent during the last decade.
The recipients are:
- Arteriocyte (Opens in a new window): The Cleveland-based stem cell company will further develop its NANEX (Opens in a new window) technology, which uses stem cells to create (pdf) “universal-donor” red blood cells (Opens in a new window)
- AtriCure (Opens in a new window): The publicly traded Cincinnati-area cardiac device maker will adapt its AtriClip (Opens in a new window) device to be used in minimally invasive procedures
- Bettcher Industries (Opens in a new window): The Birmingham-based manufacturing company will adapt its products for use in the fields of tissue and bone recovery, burn treatment and plastic reconstructive surgery
- OrthoHelix Surgical Designs (Opens in a new window): The Medina-based orthopedic implants firm will launch a new product line it calls the “pocket plating system (Opens in a new window),” which would involve foot and ankle implants
- PercuVision (Opens in a new window): The Columbus-area urological catheterization company will develop the next generation of its product, which is designed to improve catheter insertions (Opens in a new window) into the urethra
- U.S. Endoscopy (Opens in a new window): The Mentor-based endoscopic products maker will expand its product offerings in the urological market
- VasoStar (Opens in a new window): The Mentor-based company will conduct a safety study on its guide wire system designed to help cardiologists penetrate blood-vessel blockage to place stents in the heart
- Imalux (Opens in a new window): The Cleveland-based company will improve its imaging device that’s used to detect cancer
Case Western Reserve University (Opens in a new window) also received a nearly $1 million biomedical grant for a project with Cleveland Clinic and Proxy Biomedical to improve the manufacturing processes around a device to reduce stress urinary incontinence.